WAILMA WILLIAM: Open Payments
NPI 1659954634 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 11 companies in 2025. Trend: 2023 $186 · 2024 $191 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Janssen Biotech, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| TMS NeuroHealth Centers Inc. | 1 | $31 |
| Incyte Corporation | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
Products named: PLUVICTO, Enhertu, DARZALEX, JEMPERLI, TMS NeuroHealth Centers Inc., MONJUVI, SPRAVATO, CAPLYTA.
Industry payments across FL — which companies pay providers there.
